Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 4Recruiting 3Unknown 2Withdrawn 1Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 6392Neoplasms 5365Prostatic Neoplasms 2966Carcinoma, Non-Small-Cell Lung 2709Colorectal Neoplasms 2679Lung Neoplasms 2267Multiple Myeloma 1663Lymphoma 1600Neoplasm Metastasis 1552Leukemia, Myeloid, Acute 1540Melanoma 1486Pancreatic Neoplasms 1470Ovarian Neoplasms 1423Leukemia 1389Head and Neck Neoplasms 1284Precursor Cell Lymphoblastic Leukemia-Lymphoma 1282Lymphoma, Non-Hodgkin 1231Colonic Neoplasms 1159Carcinoma, Hepatocellular 1142Stomach Neoplasms 1129Leukemia, Lymphocytic, Chronic, B-Cell 1090Brain Neoplasms 1050Rectal Neoplasms 980Lymphoma, Follicular 979Recurrence 976Uterine Cervical Neoplasms 926Glioblastoma 920Carcinoma, Renal Cell 882Lymphoma, Large B-Cell, Diffuse 853Hodgkin Disease 777

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Peripheral Arterial Disease × Clear all
NCT03960463 2025-01-23

EO2 Oxygen Delivery To Study Success Rate of Surgically Closed Wounds

Baylor College of Medicine

Phase NA Completed
33 enrolled 13 charts
Breast

Surgical Wound, Breast Neoplasms, Cicatrix, Diabetes Mellitus, Infections, Diabetic Foot, Peripheral Arterial Disease

NCT06234280 2024-01-31

K-ELUVIA

Yonsei University

Completed
100 enrolled
Lymphoid

Chronic Limb-Threatening Ischemia, Intermittent Claudication, Lymphoma, Follicular, Peripheral Arterial Disease

NCT05116696 2021-11-11

Comparison of Outcomes of Patients With Stage IV Chronic Limb-threatening Ischemia and Colorectal Cancer

Clinical Centre of Serbia

Completed
836 enrolled
Gastrointestinal

Chronic Limb-Threatening Ischemia, Colorectal Neoplasms, Peripheral Arterial Disease

NCT02819011 2020-02-27

OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO

Baylor College of Medicine

Phase 2 Completed
44 enrolled 16 charts

Frailty, Arthritis, Diabetes Mellitus, Neoplasms, Parkinson Disease, Peripheral Arterial Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡